MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

08 Aug 2026 Evaluate
The sales moved down -36.56% to Rs. 0.59 millions for the June 2026 quarter as compared to Rs. 0.93 millions during the corresponding quarter last year.Net profit declined -23.98% to Rs. 1.30 millions from Rs. 1.71 millions.The company reported a degrowth in operating Profit to 1.86 millions from 2.57 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 0.59 0.93 -36.56 0.59 0.93 -36.56 3.71 6.11 -39.28
Other Income 5.39 5.34 0.94 5.39 5.34 0.94 20.36 20.09 1.34
PBIDT 1.86 2.57 -27.63 1.86 2.57 -27.63 6.83 10.58 -35.44
Interest 0.01 0.01 0.00 0.01 0.01 0.00 0.02 0.01 100.00
PBDT 1.85 2.56 -27.73 1.85 2.56 -27.73 6.81 10.57 -35.57
Depreciation 0.23 0.25 -8.00 0.23 0.25 -8.00 1.00 0.98 2.04
PBT 1.62 2.31 -29.87 1.62 2.31 -29.87 5.81 9.59 -39.42
TAX 0.32 0.60 -46.67 0.32 0.60 -46.67 1.44 6.42 -77.57
Deferred Tax -0.09 0.00 0.00 -0.09 0.00 0.00 -0.37 2.02 -118.32
PAT 1.30 1.71 -23.98 1.30 1.71 -23.98 4.37 3.17 37.85
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 315.25 276.34 14.08 315.25 276.34 14.08 184.10 173.16 6.32

Emmessar Biotech&Nut Share Price

25.65 0.25 (0.98%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: